0QOK stock news
This page provides real-time market news, earnings updates, and company announcements related to Roche Holding Ltd (0QOK).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-18 04:56 GMT
Top Stock Reports for Costco, Roche & Lam Research
Finviz2026-02-25 00:06:37
Deep value investor Lee Roche: You can still make a fortune from software stocks, just like trading "phone books"
华尔街见闻2026-02-25 12:45:02
Recursion Pharmaceuticals (RXRX) Hits Clinical Milestones as 2025 Revenue Grows to $74.7M
Finviz2026-02-26 19:30:41
Keros Therapeutics Appoints Charles Newton to its Board of Directors
Finviz2026-02-26 21:03:45
Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory
Finviz2026-02-28 17:01:08
礼来惊吓，诺和诺德救场！减肥药市场前景依旧令众玩家垂涎
moomoo-证劵2026-03-01 14:19:20
Is Brookfield Asset Management Ltd. (BAM) A Good Stock To Buy?
Finviz2026-03-05 17:36:46
Is Brookfield Asset Management Ltd. (BAM) A Good Stock To Buy?
Finviz2026-03-05 17:36:46
Is DaVita Inc. (DVA) A Good Stock To Buy?
Finviz2026-03-05 17:42:09
Is Waste Management, Inc. (WM) A Good Stock To Buy?
Finviz2026-03-05 20:22:04
Why Is Olema Pharmaceuticals Stock Dropping On Monday?
Finviz2026-03-09 16:25:00
BioNTech and Co-Founders Announce Plan to Pursue Next-Generation mRNA Innovations in Co-Founders-Led New Company as BioNTech Advances Toward Becoming a Multi-Product Company by 2030
Finviz2026-03-10 10:37:05
MBX Biosciences Appoints Karen Basbaum as Chief Business Officer
Finviz2026-03-10 12:03:12
Monte Rosa Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
Finviz2026-03-17 11:03:48
Financing Plan Details: Australian biotechnology company Kazia Therapeutics Limited (NASDAQ: KZIA) recently filed an F-1 form with the U.S. Securities and Exchange Commission (SEC), planning to raise up to 200 millions USD through the issuance of American Depositary Shares (ADS).
老虎证券2026-03-18 10:23:33
Breakthrough in Clinical Trial Data: Biopharmaceutical company Greenwich Lifesciences Inc (NASDAQ: GLSI) recently announced the latest analysis results of its core immunotherapy GP2 in adjuvant treatment for breast cancer.
老虎证券2026-03-18 10:24:33
BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer
Finviz2026-03-24 10:48:48
Plus Therapeutics Appoints Diagnostics and Molecular Diagnostics Industry Leader Ron Andrews to its Board of Directors
Finviz2026-03-26 11:33:44
Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria
Finviz2026-03-26 20:33:49
Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR platform
Finviz2026-03-30 13:03:03
Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-04-01 21:03:44
Former Lehman trader: Private credit is "this cycle's subprime", stay away from "crowded" tech stocks and embrace "scarce" resource stocks
追风交易台2026-04-04 12:23:00
C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs)
Finviz2026-04-09 11:03:39
Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah
Finviz2026-04-09 13:03:43
Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory
Finviz2026-02-28 17:01:08
礼来惊吓，诺和诺德救场！减肥药市场前景依旧令众玩家垂涎
moomoo-证劵2026-03-01 14:19:20
Is Brookfield Asset Management Ltd. (BAM) A Good Stock To Buy?
Finviz2026-03-05 17:36:46
Is Brookfield Asset Management Ltd. (BAM) A Good Stock To Buy?
Finviz2026-03-05 17:36:46
Is DaVita Inc. (DVA) A Good Stock To Buy?
Finviz2026-03-05 17:42:09
Is Waste Management, Inc. (WM) A Good Stock To Buy?
Finviz2026-03-05 20:22:04
Why Is Olema Pharmaceuticals Stock Dropping On Monday?
Finviz2026-03-09 16:25:00
BioNTech and Co-Founders Announce Plan to Pursue Next-Generation mRNA Innovations in Co-Founders-Led New Company as BioNTech Advances Toward Becoming a Multi-Product Company by 2030
Finviz2026-03-10 10:37:05
MBX Biosciences Appoints Karen Basbaum as Chief Business Officer
Finviz2026-03-10 12:03:12
Monte Rosa Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
Finviz2026-03-17 11:03:48
Financing Plan Details: Australian biotechnology company Kazia Therapeutics Limited (NASDAQ: KZIA) recently filed an F-1 form with the U.S. Securities and Exchange Commission (SEC), planning to raise up to 200 millions USD through the issuance of American Depositary Shares (ADS).
老虎证券2026-03-18 10:23:33
Breakthrough in Clinical Trial Data: Biopharmaceutical company Greenwich Lifesciences Inc (NASDAQ: GLSI) recently announced the latest analysis results of its core immunotherapy GP2 in adjuvant treatment for breast cancer.
老虎证券2026-03-18 10:24:33
BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer
Finviz2026-03-24 10:48:48
Plus Therapeutics Appoints Diagnostics and Molecular Diagnostics Industry Leader Ron Andrews to its Board of Directors
Finviz2026-03-26 11:33:44
Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria
Finviz2026-03-26 20:33:49
Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR platform
Finviz2026-03-30 13:03:03
Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-04-01 21:03:44
Former Lehman trader: Private credit is "this cycle's subprime", stay away from "crowded" tech stocks and embrace "scarce" resource stocks
追风交易台2026-04-04 12:23:00
C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs)
Finviz2026-04-09 11:03:39
Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah
Finviz2026-04-09 13:03:43
0QOK stock price change
On the last trading day, 0QOK stock closed at 319.75 GBP, with a price change of 0.00% for the day.
Trade stock perps0QOK stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more